TrialThe journal of headache and pain2024

Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Shengyuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.